Quantifying the response to antiepileptic drugs: effect of past treatment history.
about
Anti-epileptogenic clinical trial designs in epilepsy: issues and optionsModern antiepileptic drug development has failed to deliver: ways out of the current dilemma.Surgical management of epilepsy.The Role of Stereotactic Laser Amygdalohippocampotomy in Mesial Temporal Lobe Epilepsy.Pharmacoresistance and the role of surgery in difficult to treat epilepsy.Remission of epilepsy after two drug failures in children: a prospective study.Rational Polytherapy with Antiepileptic Drugs.Treatment strategy for the patient with hippocampal sclerosis who failed to the first antiepileptic drugDrug-Resistant Epilepsy: Multiple Hypotheses, Few AnswersThe EULEV cohort study: rates of and factors associated with continuation of levetiracetam after 1 year.Pharmacogenomic association study on the role of drug metabolizing, drug transporters and drug target gene polymorphisms in drug-resistant epilepsy in a north Indian populationRemission and relapse in a drug-resistant epilepsy population followed prospectively.Treatment of epilepsy in China: Formal or informal.Possible role of CYP2C9 & CYP2C19 single nucleotide polymorphisms in drug refractory epilepsySuppression of seizure by cathodal transcranial direct current stimulation in an epileptic patient - a case report -.Real-world data on eslicarbazepine acetate as add-on to antiepileptic monotherapyPatterns of treatment response in newly diagnosed epilepsy.Emerging drugs for partial-onset epilepsy: a review of brivaracetamPromoter Variants of the ADAM10 Gene and Their Roles in Temporal Lobe Epilepsy.Efficacy and safety of brivaracetam for partial-onset seizures in 3 pooled clinical studies.Epilepsy, cognition, and neuropsychiatry (Epilepsy, Brain, and Mind, part 2)Health and economic benefits of public financing of epilepsy treatment in India: An agent-based simulation model.Differential role of sodium channels SCN1A and SCN2A gene polymorphisms with epilepsy and multiple drug resistance in the north Indian population.Noninvasive brain stimulation protocols in the treatment of epilepsy: current state and perspectives.Adjunctive antiepileptic drugs in adult epilepsy: how the first add-on could be the last.Pharmacotherapy of epilepsy: newly approved and developmental agents.Prognosis of intractable epilepsy: is long-term seizure freedom possible with medical management?Novel medications for epilepsy.Pharmacotherapy of the third-generation AEDs: lacosamide, retigabine and eslicarbazepine acetate.Pharmacokinetic and pharmacodynamic profile of pregabalin and its role in the treatment of epilepsy.Network meta-analyses of antiepileptic drug efficacy and tolerability in drug-resistant focal epilepsies: a clinical perspective.USL255 extended-release topiramate for the treatment of epilepsy.Treatment of electrical status epilepticus in sleep: A pooled analysis of 575 cases.Can Matching-Adjusted Indirect Comparison Methods Mitigate Placebo Response Differences Among Patient Populations in Adjunctive Trials of Brivaracetam and Levetiracetam?Methodological issues associated with clinical trials in epilepsy.Classification and epilepsy: the future awaits.Third generation antiepileptic drug monotherapies in adults with epilepsy.New antiepileptic drugs: focus on ezogabine, clobazam, and perampanel.EARLY-ESLI study: Long-term experience with eslicarbazepine acetate after first monotherapy failure.Risk factors for health-related quality of life in children with epilepsy: a meta-analysis.
P2860
Q27027689-D7E49279-A37B-40F7-B8E6-6C08633AF5DDQ27693823-57CFEB04-E149-4153-AD70-EF08A2828DB4Q30586882-59CC9A02-E3B7-45F7-9999-44AC1CB6F88AQ31029054-66FD5EA8-4C91-4962-870C-ABFEFD217B2DQ33161739-52CDD7CE-39B0-4C1F-B0CD-B53389D53C36Q33636027-D60FA3FC-4CB6-438B-BF13-3CB66C5745D3Q33664046-A1E0DD41-9C90-458F-811D-FD5144DBAA6DQ33790599-191A245E-10F0-4923-B41A-BD3C85E03050Q33875271-939F678F-240A-4CC6-931B-4B579E90B138Q34476131-30FE3D0D-C3DB-40F9-86DF-6981BA9C02ACQ35073509-75950811-640A-4B99-9ACA-652BFBDB20D6Q35138587-805584A6-BFFD-4B49-A707-35E3B37413CBQ35245431-DA1F1DAC-E677-4BA7-BA11-79F7247A7742Q35351731-1A71E62E-0413-4706-92B7-E243B7E0AED8Q35843345-AC096E97-2A6D-492F-8DA9-824E3BE9F670Q35936036-487584B0-0E91-4229-874B-621827B7798CQ35948540-B1207537-5054-4C3C-9AD7-3EBA8EDF144AQ36891212-74217128-DF03-44C8-9A57-566320F3CFFAQ37054395-B33C5958-E1A5-4906-8D89-64B88406D0A3Q37113376-55914DC3-F254-45AF-B9AE-DFA1D14DFA19Q37242260-87A7F634-D049-4698-B637-99CA9BD56808Q37248659-AC0C2B51-EEE3-4FD7-8B15-E7E949B03E75Q37399443-9DEC5C7C-29B8-44D6-89B3-AEDB44D12925Q37426954-CA57C231-E65E-4DB2-9D94-B680CF02F3F3Q37733552-27E6EA95-DB04-40D4-9204-94FA04AA742EQ37831297-35E2744C-B69D-45A9-A878-C28C3A43E7EEQ37860979-0361C8DA-89F8-4789-B7C5-05A1CCA0477BQ37950518-A02FFAD0-F76E-40D4-9214-89D5F63E30AFQ37992162-2B057291-49F4-478E-8674-D6475CE66F53Q38064486-F6DF1149-6ED2-4A30-B2B0-88E4E6F35126Q38199973-9FA50B46-3E9B-4D58-A9AE-C2BABCD9C465Q38249142-4B8DC4F4-B59B-401C-97C2-C1AB58765B07Q38580195-0763A5C2-8F66-4DBF-A603-74394449FD39Q38600989-2A046298-AAF0-42E5-A6D1-26F1AA1B75A4Q38656392-2EBAD23C-0DD2-40AD-B5A6-67D915D13A3AQ38701230-4604C82B-AEC6-45C6-B4DD-71872061AF4AQ38849966-24EF2EB7-8F3D-497F-9EF8-BE885E2B01C9Q38851234-1EA44941-AC88-4C13-BDB3-D07572E219A2Q39116160-AF3367FD-2EC6-417F-8C6E-8F6C98A4F0C9Q39125311-EA707C2A-D774-4B1D-8F51-C2778E1310B9
P2860
Quantifying the response to antiepileptic drugs: effect of past treatment history.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Quantifying the response to antiepileptic drugs: effect of past treatment history.
@en
Quantifying the response to antiepileptic drugs: effect of past treatment history.
@nl
type
label
Quantifying the response to antiepileptic drugs: effect of past treatment history.
@en
Quantifying the response to antiepileptic drugs: effect of past treatment history.
@nl
prefLabel
Quantifying the response to antiepileptic drugs: effect of past treatment history.
@en
Quantifying the response to antiepileptic drugs: effect of past treatment history.
@nl
P1433
P1476
Quantifying the response to antiepileptic drugs: effect of past treatment history.
@en
P2093
Yitzhak Schiller
Yussef Najjar
P356
10.1212/01.WNL.0000286959.22040.6E
P407
P577
2008-01-01T00:00:00Z